|
THE
RESEARCH DATABASE — PHARMA NORD'S FOUNDATION
Pharma Nord's research department is always at the
forefront of the latest international nutrition science.
Scientific studies and articles are carefully registered
and catalogued in the most comprehensive research database
of the industry, currently holding more than 8,000
scientific references. A considerably amount of these
studies has been conducted using Pharma Nord's own
products. The research database is continuously revised
whenever new studies of relevance to Pharma Nord's
products are published. The research department's
library is a vital tool for developing new products
and improving existing ones.
200 PUBLISHED STUDIES WITH PHARMA NORD PRODUCTS
Besides the many scientific articles and studies used
by Pharma Nord as a foundation for developing new products
and improving or updating those that already exist,
the company has conducted over 200 published studies
with products of its own. This research is the cornerstone
of the entire documentation that is so vital for the
success of Pharma Nord's products. New titles are
continuously added to database.
SCIENTIFIC DEVELOPMENT
Over the years, Pharma Nord has established a comprehensive international network of scientists in areas such as cardiology, oncology, odontology, surgery, dietary technology and several others. This collaboration, and the ongoing dialogue with researchers, is an extremely important tool for the development of our products.
 PHARMA NORD AND CANCER RESEARCH
The battle against cancer is one of the most challenging areas of medical science. Pharma Nord is actively involved in international research in cancer prevention and treatment. One of the largest and most ambitious science projects ever in this area is the international PRECISE study that focuses on the preventative properties of the trace element selenium. Pharma Nord is the official supplier of selenium tablets and placebo pills for the entire study, a population study involving 40,000 test participants from Denmark, Sweden and England.
PHARMA NORD AND HEART RESEARCH
Pharma Nord actively supports science in its efforts
to uncover new therapies for heart diseases, particularly
those therapies aimed at increasing quality of life
in people who, due to old age or disease, suffer
from a lack of coenzyme Q10. Among other things,
Pharma Nord has launched Q-SYMBIO, a large multinational
study, investigating coenzyme Q10's potential as
an adjuvant for treating chronic heart failure.
REFERENCE PRODUCT
Because of its good and well documented bio-availability
Pharma Nord's coenzyme Q10 preparation is a reference
product for the International Coenzyme Q10 Association
and has been tested in more than 70 studies. This research
is one of the main reasons why the preparation is able
to document such a high level of bio-availability.
What is more, the fact that it has been on the market
for close to 20 years provides good safety data for
the product.
 CONFERENCES & SYMPOSIUMS
In some areas the amount of new science surfaces so frequently, it pays off to arrange regular symposiums, where scientists from all over the world gather to present the latest scientific breakthroughs. In many cases, Pharma Nord hosts or co-hosts such events. So far, scientific symposiums and conferences have been arranged in research areas like Q10, CLA and selenium.
THE EXPERIENCE OF THE CONSUMERS
Consumers make their own experience and this is of
invaluable importance to our existing and future
products. Although consumer experience can hardly
be classified as "scientific documentation" it
still gives a clue as to whether or no the preparations
have an effect and are generally safe to use, short-
or long-term. For this reason, Pharma Nord regards
every type of consumer feedback as something of enormous
value, and actively encourages consumers to contact
the company if there is a story to tell.
|
